Documentos relacionados

1. Molecular cloning and tissue distribution of a novel marmoset ABC transporter.
2. Methods to detect P-glycoprotein and implications for other drug resistance-associated proteins.
3. Do differences in cell lines and methods used for calculation of IC₅₀ values influence categorisation of drugs as P-glycoprotein substrates and inhibitors?
4. Assessment of verdinexor as a canine P-glycoprotein substrate.
5. Cryo-EM structure of P-glycoprotein bound to triple elacridar inhibitor molecules.
6. Overview of P-glycoprotein inhibitors: a rational outlook
7. In Vitro Evaluation of the Interaction of Seven Biologically Active Components in <i>Anemarrhenae rhizoma</i> with P-gp.
8. Imunorreatividade à glicoproteína-p nos diferentes tipos citomorfológicos de tumor venéreo transmissível canino
9. Evaluation of the effect of P-glycoprotein inhibition and induction on talazoparib disposition in patients with advanced solid tumours.
10. Detection of the MDR1 P-glycoprotein expression and function.